RayKnowChina Research Map
Shortlist

Other diseases

Pompe disease

庞贝病

An inherited disorder in which glycogen builds up in lysosomes and can affect muscles, including the heart.

Definition adapted from MeSH (US National Library of Medicine)

hospitals in mainland China
30

with a paper from 2016–2025 or a registered study

cities
17

where those hospitals are

open trials in China
1

ClinicalTrials.gov, 13 Nov 2026

Mainland China accounts for 9% of the world's English-language research papers on Pompe disease, 2021–2025 (5% in 2016–2020), and 6% of the world's registered trials on it have a site in China.

Research activity in public records, not a rating of care and not medical advice. How the numbers are made

30 hospitals in 17 cities

Order: papers led on Pompe disease, 2021–2025, then A–Z. Research activity, not a rating of care.

A hospital is listed when it led at least 1 papers or 1 trial on Pompe disease, or was a site in 1 or more trials. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first. Hospitals not listed may also treat it. Definitions

A square is a city. Its size and number are hospitals listed for this disease, not the amount of research. Choose one to show that city in the hospital list and the trial list.

Cities with the most listed hospitals

  1. Beijing6
  2. Shanghai4
  3. Changsha2
  4. Chengdu2
  5. Guangzhou2
  6. Hangzhou2
  7. Jinan2
  8. Changchun1
  9. Chongqing1
  10. Liaocheng1

Each opens Pompe disease in that city. 7 more cities are in the menu below.

  1. 2 papers led
    No open trial led
  2. 2 papers led
    No open trial led
  3. Xi'an Children's Hospital

    西安市儿童医院Xi'an

    2 papers led
    No open trial led
  4. 1 paper led
    No open trial led
  5. 1 paper led
    No open trial led
  6. 1 paper led
    No open trial led
  7. Chinese PLA General Hospital

    中国人民解放军总医院Beijing

    1 paper led
    No open trial led
  8. 1 paper led
    No open trial led
  9. 1 paper led
    No open trial led
  10. 1 paper led
    No open trial led
  11. 1 paper led
    No open trial led
  12. 1 paper led
    No open trial led
  13. 1 paper led
    No open trial led
  14. 1 paper led
    No open trial led
  15. 1 paper led
    No open trial led
  16. 1 paper led
    No open trial led
  17. 0 papers led
    No open trial led
  18. 0 papers led
    No open trial led
  19. 0 papers led
    No open trial led
  20. 0 papers led
    No open trial led
  21. 0 papers led
    No open trial led
  22. 0 papers led
    No open trial led
  23. 0 papers led
    No open trial led
  24. Shanghai Children's Medical Center

    上海交通大学医学院附属上海儿童医学中心Shanghai

    0 papers led
    No open trial led
  25. Shengjing Hospital of China Medical University

    中国医科大学附属盛京医院Shenyang

    0 papers led
    No open trial led
  26. Sir Run Run Shaw Hospital

    浙江大学医学院附属邵逸夫医院Hangzhou

    0 papers led
    No open trial led
  27. Third Xiangya Hospital

    中南大学湘雅三医院Changsha

    0 papers led
    No open trial led
  28. West China Second University Hospital

    四川大学华西第二医院Chengdu

    0 papers led
    No open trial led
  29. Xiangya Hospital

    中南大学湘雅医院Changsha

    0 papers led
    No open trial led
  30. Xinhua Hospital

    上海交通大学医学院附属新华医院Shanghai

    0 papers led
    No open trial led

By university or health system 6

Hospitals carrying a university’s name, added together, plus papers that name only the university. Same order as above.

  1. Shandong University

    山东大学Jinan

    2 papers led
    1 hospital
  2. Sichuan University (West China)

    四川大学华西Chengdu

    2 papers led
    1 hospital
  3. Xi'an Jiaotong University

    西安交通大学Xi'an

    2 papers led
    1 hospital
  4. Chinese PLA General Hospital

    中国人民解放军总医院Beijing

    1 paper led
    1 hospital
  5. Fudan University

    复旦大学Shanghai

    1 paper led
    1 hospital
  6. Shanghai Jiao Tong University School of Medicine

    上海交通大学医学院Shanghai

    0 papers led
    0 hospitals

1

open trial on Pompe disease in China

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 13 Nov 2026, with at least one listed hospital as lead sponsor or site, and at least one listed hospital's site marked open. 0 of them are led by a listed hospital. Check the registry for the current status. Whether someone can take part is decided by the study team.

Trials registered only in China’s own registry (ChiCTR) are not included. Questions to check before asking about a trial

What the phases mean (US National Cancer Institute)

  1. Recruiting
    Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug
    Phase
    Phase 1/Phase 2
    Started
    2024-04
    Registry
    NCT06391736

    Age 6 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteBeijing

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

Where these numbers come from

Papers

30 English-language PubMed papers on Pompe disease with an author in mainland China, 2021–2025; a hospital led a paper when its first or last author lists it first. Run the PubMed search

Trials

ClinicalTrials.gov records with a listed hospital as lead sponsor or site, as of 13 Nov 2026. ChiCTR is not included. Search ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data (CSV)Definitions